1.14HKD
4.16 BHKD
286.81 BHKD
698.44 M
About SHANGHAI PHARMACEUTICALS HOLDING CO
Sector
Headquarters
Shanghai
Employees (FY)
48.16 K
Website
Founded
1994
ISIN
CNE1000012B3
FIGI
BBG0015W4KX6
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research and development, manufacture, distribution, and retail of pharmaceutical products. The company was founded on January 18, 1994 and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2607 is 10.96 HKD — it has increased by 1.67% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SHANGHAI PHARMACEUTICALS HOLDING CO stocks are traded under the ticker 2607.
SHANGHAI PHARMACEUTICALS HOLDING CO is going to release the next earnings report on Apr 27, 2024. Keep track of upcoming events with our Earnings Calendar.
2607 stock is 3.18% volatile and has beta coefficient of 0.62. Check out the list of the most volatile stocks — is SHANGHAI PHARMACEUTICALS HOLDING CO there?
One year price forecast for SHANGHAI PHARMACEUTICALS HOLDING CO has a max estimate of 18.58 HKD and a min estimate of 12.90 HKD.
2607 earnings for the last quarter are 0.34 HKD per share, whereas the estimation was 0.43 HKD resulting in a −20.99% surprise. The estimated earnings for the next quarter are 0.57 HKD per share. See more details about SHANGHAI PHARMACEUTICALS HOLDING CO earnings.
SHANGHAI PHARMACEUTICALS HOLDING CO revenue for the last quarter amounts to 69.63 B HKD despite the estimated figure of 75.58 B HKD. In the next quarter revenue is expected to reach 69.14 B HKD.
Yes, you can track SHANGHAI PHARMACEUTICALS HOLDING CO financials in yearly and quarterly reports right on TradingView.
2607 stock has fallen by 0.54% compared to the previous week, the month change is a 5.19% fall, over the last year SHANGHAI PHARMACEUTICALS HOLDING CO has showed a 30.37% decrease.
2607 net income for the last quarter is −31.10 M HKD, while the quarter before that showed 1.28 B HKD of net income which accounts for −102.43% change. Track more SHANGHAI PHARMACEUTICALS HOLDING CO financial stats to get the full picture.
Today SHANGHAI PHARMACEUTICALS HOLDING CO has the market capitalization of 39.92 B, it has decreased by 4.42% over the last week.
Yes, 2607 dividends are paid annually. The last dividend per share was 0.66 HKD. As of today, Dividend Yield (TTM)% is 6.16%. Tracking SHANGHAI PHARMACEUTICALS HOLDING CO dividends might help you take more informed decisions.
SHANGHAI PHARMACEUTICALS HOLDING CO dividend yield was 3.59% in 2023, and payout ratio reached 36.45%. The year before the numbers were 5.11% and 35.39% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 2607 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI PHARMACEUTICALS HOLDING CO stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 48.16 K employees. See our rating of the largest employees — is SHANGHAI PHARMACEUTICALS HOLDING CO on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI PHARMACEUTICALS HOLDING CO technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI PHARMACEUTICALS HOLDING CO stock shows the strong sell signal. See more of SHANGHAI PHARMACEUTICALS HOLDING CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SHANGHAI PHARMACEUTICALS HOLDING CO future price: according to them, 2607 price has a max estimate of 18.59 HKD and a min estimate of 12.90 HKD. Read a more detailed SHANGHAI PHARMACEUTICALS HOLDING CO forecast: see what analysts think of SHANGHAI PHARMACEUTICALS HOLDING CO and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANGHAI PHARMACEUTICALS HOLDING CO EBITDA is 11.43 B HKD, and current EBITDA margin is 4.07%. See more stats in SHANGHAI PHARMACEUTICALS HOLDING CO financial statements.